The drug industry is riddled with rebates to hide the actual cost. PBMs use the rebates in exchange for access on their formulary. Other rebates or charge backs administered through the wholesaler reduce the cost Continue Reading
We believe that genetic testing for drug compatibility is a powerful tool to combat addiction. This is a key component in our RX management programs. Read more in this article from Larry Saunders, President Continue Reading
The FDA Just Approved the First Direct Competitor to a Billion-Dollar Cancer Drug – BusinessInsider.com
No comment
A billion dollar drug gets competition from a biosimilar drug. Read more here: https://amp-businessinsider-com.cdn.ampproject.org/c/s/amp.businessinsider.com/fda-approves-avastin-biosimilar-to-treat-cancer-2017-9Continue Reading
Drugs can have dramatically lower costs in other countries. These drugs can be manufactured in the same plant as the US drugs. A number of legislators see this as an opportunity to reduce the cost of medications Continue Reading
What to Ask Your Pharmacy Benefit Manager to Control Spike in Prescription Spending – Workforce.com
No comment
PBM’s are under scrutiny as demonstrated in the article. Read more from Workforce.com, link here: http://www.workforce.com/2017/08/29/ask-pharmacy-benefit-manager-control-spike-prescription-spending/Continue Reading
Local towns are trying to sue drug companies for marketing that is resulting in addiction. Read more from the Hartford Courant here: Continue Reading
Pharmaceuticals can be important in pain management. They can also cause a patient to become addicted. There is a fine line when narcotics are prescribed between help or hurt. Read more from the Hartford Courant Continue Reading
Some believe that the transparency of the PBM’s is contributing to the high drug costs. This is evident with the Higher cost branded drugs. Read more from Prospect.org at this link: Continue Reading
This is an example of United being greedy in my opinion. There is a need for greater transparency in the pharmaceutical delivery system to identify these practices. Read more from KSLA here: Continue Reading
My background in the pharmaceutical industry primarily comes from the generic drug industry. I was involved in the pioneering stage when generic drugs were considered less than equal to a branded pharmaceuticals. Continue Reading